LILLY FDA Approval ANDA 060004

ANDA 060004

LILLY

FDA Drug Application

Application #060004

Application Sponsors

ANDA 060004LILLY

Marketing Status

Discontinued001
Discontinued002

Application Products

001FOR SOLUTION;ORALEQ 125MG BASE/5ML0V-CILLIN KPENICILLIN V POTASSIUM
002FOR SOLUTION;ORALEQ 250MG BASE/5ML0V-CILLIN KPENICILLIN V POTASSIUM

FDA Submissions

ORIG1AP1967-04-07
LABELING; LabelingSUPPL11AP1993-09-23
LABELING; LabelingSUPPL13AP1994-03-14

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 60004
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.